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Edited by Judit Ova´diAbstract To identify the sequence of hydroxyacid-oxoacid
transhydrogenase (HOT), responsible for the oxidation of 4-
hydroxybutyrate in mammalian tissues, we have puriﬁed this en-
zyme from rat liver and obtained partial sequences of proteins
coeluting with the enzymatic activity in the last puriﬁcation step.
One of the identiﬁed proteins was ‘iron-dependent alcohol dehy-
drogenase’, an enzyme encoded by a gene present on human
chromosome 8q 13.1 and distantly related to bacterial 4-hydrox-
ybutyrate dehydrogenases. The identiﬁcation of this protein as
HOT was conﬁrmed by showing that overexpression of the
mouse homologue in HEK cells resulted in the appearance of
an enzyme catalyzing the a-ketoglutarate-dependent oxidation
of 4-hydroxybutyrate to succinate semialdehyde.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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4-Hydroxybutyrate (c-hydroxybutyrate), a compound
known for its anesthetic properties and an abuse drug, is used
as a sleep regulator in the treatment of catalepsy [1]. 4-Hydrox-
ybutyrate is endogenously produced in mammals through
reduction of succinate semialdehyde, a product of c-aminobu-
tyrate deamination [2]. It is also formed by enzymatic oxida-
tion of 1,4-butanediol, an industrial solvent, or through
hydrolysis of c-butyrolactone. Unlike many other alcohols,
which are oxidized by NAD-linked dehydrogenases, 4-hydrox-
ybutyrate is metabolized to succinate semialdehyde by an en-
zyme (hydroxyacid-oxoacid transhydrogenase, HOT) that
does not use free NAD or NADP, but a-ketoglutarate as an
acceptor, converting it to D-2-hydroxyglutarate [3]. D-2-
Hydroxyglutarate is oxidized by a mitochondrial, FAD-linked
D-2-hydroxyglutarate dehydrogenase, which shows a low Km
(2 lM) for its substrate and thereby normally maintains
the D-2-hydroxyglutarate concentration at a low level [4,5].
Despite the critical role played by HOT in the formation of
D-2-hydroxyglutarate and the metabolism of 4-hydroxybuty-
rate and L-3-hydroxybutyrate (another substrate on which it
acts much more slowly [3,6]), the sequence encoding this en-
zyme is not known. This identiﬁcation is reported in the pres-
ent paper.Abbreviation: HOT, hydroxyacid-oxoacid transhydrogenase
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2.1. Materials
NADP-linked succinate semialdehyde dehydrogenase [7] (used as a
coupling enzyme in the HOT assay) was overexpressed at 37 C in
Bl21 cells harboring a pET15b vector driving the expression of this en-
zyme. The enzyme was extracted and puriﬁed on DEAE–Sepharose
according to previously described procedures [8]. About 130 U with
a speciﬁc activity of 6.2 U/mg protein were obtained from a 200 ml
culture.
2.2. Partial puriﬁcation of HOT from rat liver
Frozen rat livers (15 g) were homogenized with 2 volumes (v/w) of
buﬀer A (20 mM HEPES, pH 7.1, 1 lg/ml leupeptin and 1 lg/ml anti-
pain) containing 100 mM KCl. After addition of 2% poly(ethylenegly-
col) 6000, the extract was centrifuged for 15 min at 15000·g. The
supernatant (32 ml) was diluted 3-fold with buﬀer A and applied onto
a DEAE–Sepharose column (1.5 · 20 cm) equilibrated in the same buf-
fer. The column was washed with 30 ml buﬀer A and the retained pro-
teins were eluted with a 0–0.75 M NaCl gradient in 2 · 150 ml of buﬀer
A. The most active fractions (15 ml) from two such columns were
pooled, supplemented with 1 M NaCl and applied onto a phenyl se-
pharose column (6 ml) equilibrated with buﬀer A containing 1 M
NaCl. Proteins were eluted with a stepwise, decreasing gradient of
NaCl (1, 0.5, 0.3, 0.2, 0.1 to 0 M; 5 ml/fraction). The active fractions
(15 ml) were pooled and concentrated to 2 ml on an Amicon YM10 ﬁl-
ter. This preparation, which was free from succinate semialdehyde
reductase, succinate semialdehyde dehydrogenase and glutamate dehy-
drogenase, was used for the determination of the kinetic properties. A
portion (0.3 ml) of the preparation was gel-ﬁltered on a 24 cm3 Super-
dex 200 column equilibrated with 20 mM HEPES, pH 7.1, 100 mM
NaCl, 1 lg/ml leupeptin and 1 lg/ml antipain.
For tissue distribution studies, frozen rat tissues (300–400 mg) were
homogenized in 4 vol. of buﬀer A containing 25 mM KCl. Triton X-
100 and poly(ethyleneglycol) 6000 were added to ﬁnal concentrations
of 0.1% and 2%, respectively, and the homogenates were centrifuged
for 15 min at 13000·g. The supernatants were diluted with 2 vol. of
buﬀer A and 2-ml portions were applied on 0.5 ml DEAE–Sepharose
columns (equilibrated with buﬀer A). The columns were washed with
this buﬀer and the retained proteins were eluted with a stepwise NaCl
gradient (50, 100, 150, 200, 500 mM in buﬀer A; 1 ml per fraction).
HOT activity measurements were performed on 25 or 50 ll samples
of the fractions.
2.3. Overexpression of mouse HOT in HEK cells
The open reading frame of mouse HOT (NM-175236.2) was PCR-
ampliﬁed using Pwo DNA polymerase, mouse liver cDNA as a
template, and the following primers: 5 0 GAATTCGCCACCATGGC-
TGCAGCTGCACGC 3 0 (which contains an EcoRI site and a perfect
Kozak consensus sequence) and 5 0 AGATCTTAGTACAGTTTC-
ATGGATGCTTCA 3 0 (containing a BamHI site). The PCR product
was inserted between the EcoRI and BamHI sites of pCMV5 (Nova-
gen). Transfections of human embryonic kidney (HEK 293) cells were
performed as previously described [9]. 48 h after transfection, the cells
were washed with phosphate buﬀer saline and harvested in 500 ll of
buﬀer B (20 mM HEPES, pH 7.1, 5 lg/ml leupeptin, 5 lg/ml antipain).
They were frozen in liquid nitrogen, thawed, and after addition of 0.1%
Triton X-100, the cell extracts were centrifuged for 20 s at 2000·g. Theblished by Elsevier B.V. All rights reserved.
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applied on a 0.5 ml DEAE–Sepharose column equilibrated in the same
buﬀer. The column was washed with this buﬀer and retained proteins
were eluted with a stepwise NaCl gradient (see above). The enzymatic
activity was mainly present (>85%) in the fraction eluted with 100 mM
NaCl.
2.4. Enzymatic assays
All enzyme assays were carried out at 30 C in 1 ml assay mixtures.
Unless otherwise stated, HOT activity was determined spectrophoto-
metrically at 340 nm in an assay mixture containing 20 mM HEPES,
pH 7.1, 25 mM KCl, 0.5 mM NADP+, 20 mU of Escherichia coli suc-
cinate semialdehyde dehydrogenase, 0.2 mM a-ketoglutarate, 0.2 mM
4-hydroxybutyrate and the enzyme preparation to be tested. One unit
of enzyme is the amount catalyzing the formation of 1 lmol/min under
these assay conditions. HOT assays in which the formation of a-keto-
glutarate was followed contained unless otherwise indicated 50 mM
HEPES, pH 7.1, 10 mMNH4Cl, 0.2 mM NADH, 1 ll glutamate dehy-
drogenase (from Roche), 0.4 mM D-2-hydroxyglutarate and 25 lM
succinate semialdehyde. Succinate semialdehyde dehydrogenase was
assayed in a mixture containing 20 mM HEPES, pH 7.1, 25 mM
KCl, 0.5 mM NADP+ and 50 lM succinate semialdehyde.Fig. 1. Coelution of the transhydrogenase with 50 and 55 kDa
proteins in the Superose step. A portion (0.3 ml) of the preparation
was gel-ﬁltered on Superdex equilibrated with 20 mM HEPES, pH 7.1,
100 mM NaCl, 1 lg/ml leupeptin and 1 lg/ml antipain. Fractions of
0.5 ml were collected and the activity measured (closed circles).
Fractions were also analyzed by SDS–PAGE. The indicated bands
were cut out from the gel and analyzed by mass spectrometry after
trypsin digestion.3. Results
3.1. Puriﬁcation and partial characterization of the
transhydrogenase from rat liver
HOT was puriﬁed from rat liver by chromatography on
DEAE–Sepharose, phenyl sepharose and gel ﬁltration on
Superdex. During this puriﬁcation, HOT was assayed by mon-
itoring the 4-hydroxybutyrate- and a-ketoglutarate-dependent
formation of succinate semialdehyde with puriﬁed E. coli
NADP-linked succinate semialdehyde dehydrogenase as cou-
pling enzyme. Due to the presence of interfering dehydrogen-
ases, this assay could not be used in crude liver extracts, but
well after the ﬁrst chromatographic step. Assuming that the
yield of enzyme was 100% in this step, the overall puriﬁcation
factor of the enzyme was 10-fold after the ﬁrst step, 200-
fold after the second and 1300-fold after the third step (not
shown). The yields through the second and third steps were
53% and 60%, respectively.
The preparation obtained after the second chromatographic
step was free from succinate semialdehyde reductase, succinate
semialdehyde dehydrogenase and glutamate dehydrogenase
and therefore suitable for kinetic studies. When monitoring
succinate semialdehyde formation, we found that the enzyme
activity was totally dependent on the presence of both 4-
hydroxybutyrate and a-ketoglutarate for which Km values of
60 ± 6 and 85 ± 7 lM were obtained, respectively. The enzy-
matic activity was unaﬀected by 1 mM EDTA or EGTA, but
was inhibited by phenanthroline and cyanide, which caused
50% inhibition at 0.75 mM and 75 lM, respectively. However,
no stimulation of the enzymatic activity was observed with 10–
50 lM Fe2+, Fe3+, Co2+, Ni2+, Mn2+, Zn2+, or 1 mM Mg2+ or
Ca2+ (not shown).
The activity was also measured in the opposite direction, by
following the formation of a-ketoglutarate in the presence of
succinate semialdehyde and D-2-hydroxyglutarate. The Km
value was <10 lM for succinate semialdehyde and 4.5 mM
for D-2-hydroxyglutarate. No activity was observed when the
L-isomer of 2-hydroxyglutarate was used instead of the D-iso-
mer. Using a radiochemical assay in which radiolabeled
4-hydroxybutyrate was produced in the presence of [2-3H]
D-2-hydroxyglutarate and succinate semialdehyde, we con-ﬁrmed that the enzymatic activity is unaﬀected by NAD+ or
NADP+ (tested at up to 1 mM; results not shown).
3.2. Identiﬁcation of the transhydrogenase sequence
As shown in Fig. 1, the HOT activity coeluted with two
bands of 50 and 45 kDa in the last puriﬁcation step. These
were in-gel digested with trypsin and sequenced by mass spec-
trometry [4]. Both bands comprised mixtures of proteins: 2-
phosphoglycerate enolase (4 peptides), ‘iron-dependent alcohol
dehydrogenase’ (2 peptides) and HMG-CoA synthase (1 pep-
tide) in the upper band; aminoadipate aminotransferase (3
peptides), aminoacylase (3 peptides) and again ‘iron-dependent
alcohol dehydrogenase’ (4 peptides) in the lower band.
BLAST searches indicated that human ‘iron-dependent alco-
hol dehydrogenase’, which is encoded by the ADHFE1 gene on
chromosome 8q 13.1, is homologous to proteins of unknown
function from ﬁshes (70–90% identity), insects (58–61%),
Caenorhabditis elegans (48%) and several fungi (46–54%
sequence identity). It is more distantly related to bacterial
NAD(P)-linked dehydrogenases of diverse functions, including
Clostridium kluyveri 4-hydroxybutyrate dehydrogenase [10],
with which it shares 27% sequence identity and E. coli lactalde-
hyde reductase, an iron-dependent enzyme with known 3 D
structure [11]. Fig. 2 shows that mammalian ‘iron-dependent
alcohol dehydrogenase’ shares several of the residues that bind
the divalent metal cation in lactaldehyde dehydrogenase.
Analysis of both mouse and human ‘iron-dependent alcohol
dehydrogenase’ sequences with the Target P [12] program indi-
Fig. 3. Tissue distribution of HOT. The enzymatic activity was
determined after partial puriﬁcation on small DEAE–Sepharose
columns.
Fig. 2. Sequence alignment of the putative HOT with E. coli lactald-
hyde reductase. Putative HOT sequences from Homo sapiens (Hosa;
GI25989126), Mus musculus (Mumu, GI37589962) and Drosophila
pseudoobscura (Drps; GI54636830) are aligned with E. coli lactalde-
hyde reductase (LcRe; GI26249204). The conserved residues are in
bold. Asterisks indicate the positions of Asp39 (which discriminates
against NADP binding), Asp196, His200, His263 and His277 (metal
binding residues) in lactaldehyde reductase. The underlined residues in
the mouse sequence correspond to the peptides identiﬁed by mass
spectrometry in the enzyme puriﬁed from rat liver.
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dria, the known subcellular localization of HOT [3]. Taken
together, these ﬁndings suggested that mammalian ‘iron-
dependent alcohol dehydrogenase’ corresponded to HOT.
This identiﬁcation was conﬁrmed by overexpressing the
mouse putative transhydrogenase in HEK cells. Extracts of
cells transfected with a pCMV5 plasmid encoding this protein
displayed a HOT activity of 1.33 ± 0.44 mU/mg of soluble pro-
teins (mean ± S.E.M. of three independent transfections),
whereas the activity was undetectable (<0.05 mU/mg protein)
in cells transfected with a control plasmid. We conﬁrmed that
the enzymatic activity was dependent on the presence of both
4-hydroxybutyrate and a-ketoglutarate. The Km values were
77 ± 9 lM for a-ketoglutarate (measured in the presence of
0.1 mM 4-hydroxybutyrate) and 67 ± 12 lM for 4-hydroxybu-
tyrate (measured with 0.5 mM a-ketoglutarate), being there-
fore similar to the values obtained with the rat liver enzyme.
3.3. Tissue distribution
As shown in Fig. 3, the highest HOT activities were observed
in liver and kidneys and an intermediate activity was found in
heart, whereas no activity could be detected in brain, skeletal
muscle and lung. A similar tissue distribution was observedfor D-2-hydroxyglutarate dehydrogenase ([4] and unpublished
results).4. Discussion
Our ﬁndings indicate that mammalian ‘iron-dependent alco-
hol dehydrogenase’ [13], which had never been characterized
functionally until now, corresponds to HOT, an enzyme
responsible for 4-hydroxybutyrate metabolism in mammalian
cells. This identiﬁcation rests on several ﬁndings, most partic-
ularly the observation that transfection of the corresponding
protein in HEK cells induces HOT activity. The ﬁnding that
HOT is inhibited by phenanthroline and cyanide suggests that
it uses a divalent or trivalent cation as a cofactor. However,
none of the divalent or trivalent cations that we tested stimu-
lated the enzymatic activity, presumably because the catalytic
site of the enzyme as puriﬁed from rat liver is fully occupied
by a tightly bound cation. The alignment of the HOT sequence
with E. coli lactaldehyde reductase indicates that the residues
that bind the metal ion (Asp196, His200, His263 and His277)
in the E. coli enzyme [11] are conserved in mammalian HOT.
Interestingly, this is not the case for His267. As mutation of
this residue in E. coli lactaldehyde reductase favors Zn2+ bind-
ing over Fe2+ binding [14], its lack of conservation in HOT
suggests that a metal ion diﬀerent from iron may be present
in the catalytic site of this enzyme.
Kaufman et al. [3] hypothesized that a tightly bound cofac-
tor in HOT served as an intermediate acceptor for the hydride
that is transferred from the reduced substrate to the acceptor.
The ﬁnding that the enzyme is homologous to NAD(P)-depen-
dent dehydrogenases suggests that this cofactor is a pyridine
nucleotide, most likely NAD since the residue (Asp39) that dis-
criminates against NADP binding in E. coli lactaldehyde
reductase [11] is conserved in HOT. The use of a pyridine
nucleotide by HOT is consistent with the ﬁnding that this en-
zyme does not catalyze an exchange of deuteride from deuter-
ated substrates with protons of water [3]. Such an exchange
would be expected with hydride acceptors in which the hydro-
gens are transferred onto N (e.g., FAD) or O (quinones)
atoms. We conclude therefore that the reaction mechanism
of HOT is similar to the one described for malate/pyruvate
transhydrogenase a microbial enzyme that was shown to use
tightly bound NAD as an intermediate acceptor [15].
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with those reported for the puriﬁed rat kidney enzyme [3], to the
exception of the value for D-2-hydroxyglutarate, which diﬀers
by about 10-fold. This is possibly due to diﬀerences in assay
conditions. Much higher Km values for a-ketoglutarate and
succinate semialdehyde have been observed with human HOT
[6]. However, this enzyme was assayed in crude tissue extracts,
with potential interference of other enzymatic activities.
HOT is unique in using the metabolite couple a-ketoglutar-
ate/D-2-hydroxyglutarate as an electron acceptor/donor.
Thanks to the presence of D-2-hydroxyglutarate dehydroge-
nase, a low Km, FAD-linked enzyme catalysing an irreversible
reaction under physiological conditions [4,5], the a-ketoglutar-
ate/D-2-hydroxyglutarate ratio is normally maintained at an
elevated value, thus favoring the oxidation of 4-hydroxybuty-
rate to succinate semialdehyde by HOT rather than the oppo-
site conversion. This functional coupling of the two enzymes is
consistent with their similar tissue distribution (this paper),
and with the accumulation of D-2-hydroxyglutarate when suc-
cinate semialdehyde dehydrogenase is deﬁcient [16,17]. In the
last condition, succinate semialdehyde is presumably con-
stantly reduced by NADPH-linked reductases to 4-hydroxybu-
tyrate, which is reconverted to succinate semialdehyde by
HOT. This futile cycle results in the transfer of reducing equiv-
alents from NADPH to a-ketoglutarate and to a formation of
D-2-hydroxyglutarate that may exceed the capacity of D-2-
hydroxyglutarate dehydrogenase. The latter is indeed quite
low (15 nmol/min/g in liver [4]) as compared to that of
HOT (120 nmol/min/g, see Fig. 3).
The availability of the HOT sequence opens new perspec-
tives in the study of 4-hydroxybutyrate. Some of the eﬀects
of this compound may be due to its conversion to c-aminobu-
tyrate, via succinate semialdehyde. Animal models in which
HOT expression would be decreased or increased would be
invaluable to distinguish the pharmacological eﬀects that are
contributed by 4-hydroxybutyrate per se from those that are
mediated by a metabolite (e.g., c-aminobutyrate). In the latter
case, inhibitors of the transhydrogenase might be helpful in the
treatment of acute 4-hydroxybutyrate intoxications. Another
interesting perspective relates to inherited metabolic diseases.
HOT deﬁciency would likely lead to the accumulation of 4-
hydroxybutyrate in tissues and could therefore be, besides suc-
cinate semialdehyde dehydrogenase deﬁciency [18], a distinct
cause of 4-hydroxybutyric aciduria. Studies aimed at testing
this possibility will be facilitated by the identiﬁcation of the se-
quence encoding HOT.
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